Bavarian Nordic: We can adapt our vaccine if necessary

If it needs to, Bavarian Nordic will be able to keep pace with Moderna and Pfizer/Biontech and change its Covid-19 vaccine so it works against the Omicron variant.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

It is not yet known whether the current Covid-19 vaccines are effective against the Omicron variant of the coronavirus, or whether they will need to be adapted, says Rolf Sass Sørensen, vice president of investor relations at Bavarian Nordic, to MarketWire. 

"So far, the data we have seen shows that we have been able to offer just as much protection for variants as within the original strain. There has been no difference," he says, adding:

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs